Inquire Before Buying
Speak to an Analyst 
Request Brochure 
Request CustomizationIMARC made the whole process easy. Everyone I spoke with via email was polite, easy to deal with, kept their promises regarding delivery timelines and were solutions focused. From my first contact, I was grateful for the professionalism shown by the whole IMARC team. I recommend IMARC to all that need timely, affordable information and advice. My experience with IMARC was excellent and I can not fault it.
Read More
Renal Biomarkers Market Report by Biomarker Type (Functional Biomarker, Up-regulated Protein, and Others), Diagnostic Technique (Enzyme-linked Immunosorbent Assay (ELISA), Particle-enhanced Turbidimetric Immunoassay (PETIA), Colorimetric Assay, Chemiluminescent Enzyme Immunoassay (CLIA), Liquid Chromatography Mass Spectrometry (LC-MS)), End User (Hospital, Diagnostic Laboratory, and Others), and Region 2024-2032
Report Format: PDF+Excel | Report ID: SR112024A5273
Year End
sale
Buy Now
Global Renal Biomarkers Market:
The global renal biomarkers market size reached US$ 1.3 Billion in 2023. Looking forward, IMARC Group expects the market to reach US$ 2.5 Billion by 2032, exhibiting a growth rate (CAGR) of 6.9% during 2024-2032. The increasing public health concerns and its main risk factors, including hypertension, diabetes, and heart diseases, are bolstering the market.
|
Report Attribute
|
Key Statistics
|
|---|---|
|
Base Year
|
2023
|
|
Forecast Years
|
2024-2032
|
|
Historical Years
|
2018-2023
|
|
Market Size in 2023
|
US$ 1.3 Billion |
|
Market Forecast in 2032
|
US$ 2.5 Billion |
| Market Growth Rate 2024-2032 | 6.9% |
Renal Biomarkers Market Analysis:
- Major Market Drivers: The rising need for diagnosis of chronic kidney disease (CKD) and monitoring of the disease is one of the key factors bolstering the market. Additionally, the expanding healthcare industry is also acting as another significant growth-inducing factor.
- Key Market Trends: The increasing inclination among industry investors towards novel single biomarkers and process-specific biomarker panels in human renal diseases is stimulating the overall market.
- Competitive Landscape: Some of the prominent companies in the global market include Abbott Laboratories, Beckman Coulter Inc. (Danaher Corporation), bioMérieux SA, BioPorto A/S, Bio-Rad Laboratories Inc., Enzo Biochem Inc., F. Hoffmann-La Roche AG, PerkinElmer Inc., Randox Laboratories Ltd., Siemens AG, and Thermo Fisher Scientific Inc., among many others.
- Geographical Trends: North America exhibits a clear dominance in the market, owing to the increasing geriatric population. Additionally, the growing number of clinical trials for CKD will continue to fuel the regional market over the forecasted period.
- Challenges and Opportunities: One of the primary challenges hindering the market is the lack of standardization and validation across different biomarkers. However, the introduction of uniform protocols to ensure reliability and accuracy is expected to catalyze the market in the coming years.
Renal Biomarkers Market Trends:
Growing Advancements in Diagnostic Technologies
Continuous technological advancements for enhancing the precision and speed of kidney disease detection are stimulating the market. For instance, in March 2024, AI-powered pathology solutions provider Aiosyn launched its NephroPath platform to provide a detailed evaluation of histological renal biomarkers in kidney biopsies, enhancing the speed of drug development studies. Moreover, Abbott's ARCHITECT c4000, which uses advanced immunoassay techniques to measure renal biomarkers, exemplifies this trend. This is escalating the renal biomarkers market demand
Rising Prevalence of Chronic Kidney Disease
The increasing occurrence of CKD is acting as a significant growth-inducing factor. The escalating demand for early detection and monitoring tools is bolstering the market. For example, in May 2024, Bio-Techne Corporation and Regulus Therapeutics Inc. announced continued technical and clinical collaboration following the release of Regulus' positive topline results from the second cohort of patients. Apart from this, Siemens Healthineers' DCA Vantage Analyzer, which provides rapid and accurate testing for kidney function biomarkers, is positively influencing the renal biomarkers market outlook.
Expansion of Clinical Research
There is an emerging trend of expanding clinical research on renal biomarkers, driven by the rising need for better diagnostic and therapeutic solutions. Additionally, numerous clinical trials are underway to validate new biomarkers and their effectiveness, which is elevating the renal biomarkers market statistics. For instance, in March 2024, Panoramic Health, kidney care's leading integrated provider group, established its Scientific Advisory Board, a distinguished group of research experts and clinical leaders committed to advancing kidney care innovation. Apart from this, bioMérieux's NephroCheck test, which assesses the risk of acute kidney injury, has undergone extensive clinical validation, showcasing the market's focus on evidence-based products. This, in turn, is elevating the renal biomarkers market's recent price.
Global Renal Biomarkers Industry Segmentation:
IMARC Group provides an analysis of the key trends in each segment of the market, along with the renal biomarkers market forecast at the global, regional, and country levels for 2024-2032. Our report has categorized the market based on the biomarker type, diagnostic technique, and end user.
Breakup by Biomarker Type:
- Functional Biomarker
- Serum Creatinine
- Serum Cystatin C
- Urine Albumin
- Up-regulated Protein
- Neutrophil Gelatinase-Associated Lipocalin (NGAL)
- Kidney Injury Molecule-1
- INTERLEUKIN-18
- Others
Functional biomarker currently exhibits a clear dominance in the market
The report has provided a detailed breakup and analysis of the market based on the biomarker type. This includes functional biomarker(serum creatinine, serum cystatin C, and urine albumin), up-regulated protein (neutrophil gelatinase-associated lipocalin (NGAL), kidney injury molecule-1, interleukin-18), and others. According to the report, functional biomarker represented the largest market segmentation.
Functional biomarkers are measurable indicators that provide critical insights into physiological processes and disease states, enabling precise diagnosis and monitoring of therapeutic responses. Unlike traditional biomarkers, which indicate the mere presence of a disease, functional biomarkers reveal the functional status and activity of biological systems. A notable example is the recent launch of Thermo Fisher Scientific's procalcitonin assay, a functional biomarker used to assess bacterial infections and guide antibiotic therapy. This represents one of the renal biomarkers market recent opportunities.
Breakup by Diagnostic Technique:
- Enzyme-linked Immunosorbent Assay (ELISA)
- Particle-enhanced Turbidimetric Immunoassay (PETIA)
- Colorimetric Assay
- Chemiluminescent Enzyme Immunoassay (CLIA)
- Liquid Chromatography Mass Spectrometry (LC-MS)
Currently, enzyme-linked immunosorbent assay (ELISA) holds the largest renal biomarkers market share
The report has provided a detailed breakup and analysis of the market based on the diagnostic technique. This includes enzyme-linked immunosorbent assay (ELISA), particle-enhanced turbidimetric immunoassay (PETIA), colorimetric assay, chemiluminescent enzyme immunoassay (CLIA), and liquid chromatography mass spectrometry (LC-MS). According to the report, enzyme-linked immunosorbent assay (ELISA) represented the largest market segmentation.
The enzyme-linked immunosorbent assay (ELISA) is a widely used laboratory technique for detecting and quantifying antigens or antibodies in a sample, leveraging the specificity of antibodies and the sensitivity of enzyme detection. This method is essential in diagnostics, research, and quality control. A notable recent product launch is Bio-Rad Laboratories' S3e ELISA System, designed to streamline the ELISA workflow with enhanced automation and precision. This system features a user-friendly interface, high-throughput capabilities, and integrated data analysis software, making it a valuable tool for researchers and clinicians. The S3e ELISA System exemplifies advancements in ELISA technology, offering improved efficiency and accuracy in various applications, from disease diagnostics to biomarker discovery.
Breakup by End User:
- Hospital
- Diagnostic Laboratory
- Others
Diagnostic laboratory account for the majority of the total renal biomarkers market revenue
The report has provided a detailed breakup and analysis of the market based on the end user. This includes hospital, diagnostic laboratory, and others. According to the report, diagnostic laboratory represented the largest market segmentation.
Diagnostic laboratories represent the largest segmentation in the market due to their pivotal role in the early detection, diagnosis, and monitoring of kidney diseases. These laboratories are equipped with advanced technologies and skilled personnel capable of performing complex tests that measure specific renal biomarkers, such as serum creatinine, cystatin C, and neutrophil gelatinase-associated lipocalin (NGAL). The demand for accurate and timely diagnostic services is driven by the increasing prevalence of chronic kidney disease (CKD) and acute kidney injury (AKI) globally.
Breakup by Region:
- North America
- United States
- Canada
- Asia-Pacific
- China
- Japan
- India
- South Korea
- Australia
- Indonesia
- Others
- Europe
- Germany
- France
- United Kingdom
- Italy
- Spain
- Russia
- Others
- Latin America
- Brazil
- Mexico
- Others
- Middle East and Africa
North America currently dominates the market
The market research report has also provided a comprehensive analysis of all the major regional markets, which include North America (the United States and Canada); Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, and others); Europe (Germany, France, the United Kingdom, Italy, Spain, Russia, and others); Latin America (Brazil, Mexico, and others); and the Middle East and Africa. According to the report, North America accounted for the largest market share.
As per the renal biomarkers market overview, the region is characterized by significant growth due to the high prevalence of kidney diseases, advanced healthcare infrastructure, and strong focus on research and development. In the United States and Canada, there is an increasing demand for early diagnostic and monitoring tools to manage chronic kidney disease (CKD) and acute kidney injury (AKI). Prominent examples include the widespread use of BioPorto's NGAL Test, which aids in the early detection of AKI, and Abbott's ARCHITECT i2000SR system, which measures cystatin C levels to assess kidney function. The region's robust investment in healthcare technology and the presence of leading diagnostic companies drive innovation and adoption of new biomarker tests, ensuring better patient outcomes and enhancing the market's growth.
Competitive Landscape:
The market research report has provided a comprehensive analysis of the competitive landscape. Detailed profiles of all major renal biomarkers market companies have also been provided. Some of the key players in the market include:
- Abbott Laboratories
- Beckman Coulter Inc. (Danaher Corporation)
- bioMérieux SA
- BioPorto A/S
- Bio-Rad Laboratories Inc.
- Enzo Biochem Inc.
- F. Hoffmann-La Roche AG
- PerkinElmer Inc.
- Randox Laboratories Ltd.
- Siemens AG
- Thermo Fisher Scientific Inc.
(Please note that this is only a partial list of the key players, and the complete list is provided in the report.)
Renal Biomarkers Market Recent Developments:
- May 2024: Bio-Techne Corporation and Regulus Therapeutics Inc. announced continued technical and clinical collaboration following the release of Regulus' positive topline results from the second cohort of patients.
- March 2024: Panoramic Health, kidney care's leading integrated provider group, established its Scientific Advisory Board, a distinguished group of research experts and clinical leaders committed to advancing kidney care innovation.
- March 2024: AI-powered pathology solutions provider Aiosyn launched its NephroPath platform to provide a detailed evaluation of histological renal biomarkers in kidney biopsies, enhancing the speed of drug development studies.
Renal Biomarkers Market Report Scope:
| Report Features | Details |
|---|---|
| Base Year of the Analysis | 2023 |
| Historical Period | 2018-2023 |
| Forecast Period | 2024-2032 |
| Units | US$ Billion |
| Scope of the Report | Exploration of Historical Trends and Market Outlook, Industry Catalysts and Challenges, Segment-Wise Historical and Predictive Market Assessment:
|
| Biomarker Types Covered |
|
| Diagnostic Techniques Covered | Enzyme-linked Immunosorbent Assay (ELISA), Particle-enhanced Turbidimetric Immunoassay (PETIA), Colorimetric Assay, Chemiluminescent Enzyme Immunoassay (CLIA), Liquid Chromatography Mass Spectrometry (LC-MS) |
| End Users Covered | Hospital, Diagnostic Laboratory, Others |
| Regions Covered | Asia Pacific, Europe, North America, Latin America, Middle East and Africa |
| Countries Covered | United States, Canada, Germany, France, United Kingdom, Italy, Spain, Russia, China, Japan, India, South Korea, Australia, Indonesia, Brazil, Mexico |
| Companies Covered | Abbott Laboratories, Beckman Coulter Inc. (Danaher Corporation), bioMérieux SA, BioPorto A/S, Bio-Rad Laboratories Inc., Enzo Biochem Inc., F. Hoffmann-La Roche AG, PerkinElmer Inc., Randox Laboratories Ltd., Siemens AG, Thermo Fisher Scientific Inc., etc. |
| Customization Scope | 10% Free Customization |
| Report Price and Purchase Option | Single User License: US$ 3899 Five User License: US$ 4899 Corporate License: US$ 5899 |
| Post-Sale Analyst Support | 10-12 Weeks |
| Delivery Format | PDF and Excel through Email (We can also provide the editable version of the report in PPT/Word format on special request) |
Key Benefits for Stakeholders:
- IMARC's industry report offers a comprehensive quantitative analysis of various market segments, historical and current market trends, market forecasts, and dynamics of the renal biomarkers market from 2018-2032.
- The research report provides the latest information on the market drivers, challenges, and opportunities in the global renal biomarkers market.
- The study maps the leading, as well as the fastest-growing, regional markets. It further enables stakeholders to identify the key country-level markets within each region.
- Porter's five forces analysis assists stakeholders in assessing the impact of new entrants, competitive rivalry, supplier power, buyer power, and the threat of substitution. It helps stakeholders to analyze the level of competition within the renal biomarkers industry and its attractiveness.
- The competitive landscape allows stakeholders to understand their competitive environment and provides insight into the current positions of key players in the market.
The global renal biomarkers market was valued at US$ 1.3 Billion in 2023.
We expect the global renal biomarkers market to exhibit a CAGR of 6.9% during 2024-2032.
The sudden outbreak of the COVID-19 pandemic had led to the postponement of elective Chronic Kidney Disease (CKD) treatments to reduce the risk of the coronavirus infection upon hospital visits and interaction with medical equipment, thereby negatively impacting the global market for renal biomarkers testing.
The rising demand for renal biomarkers in diagnosing and monitoring Chronic Kidney Disease (CKD), predicting disease progression, and computing drug dosage is primarily driving the global renal biomarkers market growth.
Based on the biomarker type, the global renal biomarkers market can be segmented into functional biomarker, up-regulated protein, and others. Currently, functional biomarker holds the majority of the total market share.
Based on the diagnostic technique, the global renal biomarkers market has been divided into Enzyme-linked Immunosorbent Assay (ELISA), Particle-enhanced Turbidimetric Immunoassay (PETIA), colorimetric assay, Chemiluminescent Enzyme Immunoassay (CLIA), and Liquid Chromatography Mass Spectrometry (LC-MS). Among these, Enzyme-linked Immunosorbent Assay (ELISA) currently exhibits a clear dominance in the market.
Based on the end user, the global renal biomarkers market can be categorized into hospital, diagnostic laboratory, and others. Currently, diagnostic laboratory accounts for the largest market share.
On a regional level, the market has been classified into North America, Asia-Pacific, Europe, Latin America, and Middle East and Africa, where North America currently dominates the global market.
Some of the major players in the global renal biomarkers market include Abbott Laboratories, Beckman Coulter Inc. (Danaher Corporation), bioMérieux SA, BioPorto A/S, Bio-Rad Laboratories Inc., Enzo Biochem Inc., F. Hoffmann-La Roche AG, PerkinElmer Inc., Randox Laboratories Ltd., Siemens AG, and Thermo Fisher Scientific Inc.
Need more help?
- Speak to our experienced analysts for insights on the current market scenarios.
- Include additional segments and countries to customize the report as per your requirement.
- Gain an unparalleled competitive advantage in your domain by understanding how to utilize the report and positively impacting your operations and revenue.
- For further assistance, please connect with our analysts.
Benefits of Customization
Personalize this research
Triangulate with your data
Get data as per your format and definition
Gain a deeper dive into a specific application, geography, customer, or competitor
Any level of personalization
Get in Touch With Us
UNITED STATES
Phone: +1-631-791-1145
INDIA
Phone: +91-120-433-0800
UNITED KINGDOM
Phone: +44-753-714-6104
Email: sales@imarcgroup.com
Client Testimonials
The IMARC team was very reactive and flexible with regard to our requests. A very good overall experience. We are happy with the work that IMARC has provided, very complete and detailed. It has contributed to our business needs and provided the market visibility that we required
Read More
We were very happy with the collaboration between IMARC and Colruyt. Not only were your prices competitive, IMARC was also pretty fast in understanding the scope and our needs for this project. Even though it was not an easy task, performing a market research during the COVID-19 pandemic, you were able to get us the necessary information we needed. The IMARC team was very easy to work with and they showed us that it would go the extra mile if we needed anything extra
Read More
Last project executed by your team was as per our expectations. We also would like to associate for more assignments this year. Kudos to your team.
Read More.webp)
We would be happy to reach out to IMARC again, if we need Market Research/Consulting/Consumer Research or any associated service. Overall experience was good, and the data points were quite helpful.
Read More
The figures of market study were very close to our assumed figures. The presentation of the study was neat and easy to analyse. The requested details of the study were fulfilled. My overall experience with the IMARC Team was satisfactory.
Read More
The overall cost of the services were within our expectations. I was happy to have good communications in a timely manner. It was a great and quick way to have the information I needed.
Read More
My questions and concerns were answered in a satisfied way. The costs of the services were within our expectations. My overall experience with the IMARC Team was very good.
Read More
I agree the report was timely delivered, meeting the key objectives of the engagement. We had some discussion on the contents, adjustments were made fast and accurate. The response time was minimum in each case. Very good. You have a satisfied customer.
Read More.webp){kind=logo}
We would be happy to reach out to IMARC for more market reports in the future. The response from the account sales manager was very good. I appreciate the timely follow ups and post purchase support from the team. My overall experience with IMARC was good.
Read More
IMARC was a good solution for the data points that we really needed and couldn't find elsewhere. The team was easy to work, quick to respond, and flexible to our customization requests.
Read More
IMARC did an outstanding job in preparing our study. They were punctual and precise, delivering all the data we required in a clear and well-organized format. Their attention to detail and ability to meet deadlines was impressive, making them a reliable partner for our project.
Read More
I wanted to express my sincere appreciation for your efforts in handling this matter. Your dedication and commitment have truly been commendable. It is evident that you have put in a tremendous amount of hard work and expertise into resolving the issues at hand. I would also like to take this opportunity to inform you that we are greatly interested
Read More
Overall, the deliverable was well organized and my experience with the project team was good. In particular, I appreciated how they responded when I requested additional information and the Japanese version.
Read More
The IMARC team were extremely professional and very cooperative. The team were also extremely flexible in making changes and modifications wherever required. The entire experience right from project kick-off to after sales support was fruitful and smooth.
Read More
I’d like to express my gratitude for the work you accomplished with the industry report. The way you responded to the requirements and delivered under tight timelines shows your expertise, exceptional work ethic and commitment to your customer’s success. The entire team and company are incredibly thankful for your dedication. Once again, thank you
Read More
The market reports from IMARC have been instrumental in guiding our business strategies. We found the reports comprehensive and data-driven, which helped us make informed decisions. The detailed insights and actionable data have consistently provided us with a competitive edge in a rapidly changing alcohol market.
Read More
One of the best things about IMARC is their flexibility and predisposition to tailor the reports and adapt to our needs. They are not just great in their researching and consulting solutions, but their service is unparallelled. We’ve worked with them a couple of times and we will keep working with them in future projects.
Read More
We recently commissioned multiple market research reports from IMARC, and the insights we received were invaluable. The depth of analysis, accuracy of data, and actionable recommendations have greatly enhanced our strategic decision-making.
Read More
The market estimates provided by your team were pretty much in line with what we were theorizing internally. Really appreciate the work on this.
Read More
The sale account manager and the service was excellent. The data and market trends gathered from the report was insightful and really assisted while planning future product and growth strategies.
Read More
The report is excellent and has good amount of data and our team is extremely happy with the information provided.
Read More
Thank you very much for your cooperation and post purchase support. We were really happy with the final deliverable, and the takeaways from the report.
Read More